High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints.
Lisio MA, Fu L, Goyeneche A, Gao ZH, Telleria C.
Int J Mol Sci. 2019 Feb 22;20(4):952. doi: 10.3390/ijms20040952.
PMID:30813239
Life Modifications and PCOS: Old Story But New Tales.
Gu Y, Zhou G, Zhou F, Wu Q, Ma C, Zhang Y, Ding J, Hua K.
Front Endocrinol (Lausanne). 2022 Apr 13;13:808898. doi: 10.3389/fendo.2022.808898. eCollection 2022.
PMID:35498415
Medical Management of Ovarian Endometriomas: A Systematic Review and Meta-analysis.
Eberle A, Nguyen DB, Smith JP, Mansour FW, Krishnamurthy S, Zakhari A.
Obstet Gynecol. 2024 Jan 1;143(1):53-66. doi: 10.1097/AOG.0000000000005444. Epub 2023 Nov 9.
PMID:37944155
The efficacy and safety of GLP-1 agonists in PCOS women living with obesity in promoting weight loss and hormonal regulation: A meta-analysis of randomized controlled trials.
Austregésilo de Athayde De Hollanda Morais B, Martins Prizão V, de Moura de Souza M, Ximenes Mendes B, Rodrigues Defante ML, Cosendey Martins O, Rodrigues AM.
Anti-mullerian hormone as a diagnostic biomarker for polycystic ovary syndrome and polycystic ovarian morphology: a systematic review and meta-analysis.
van der Ham K, Laven JSE, Tay CT, Mousa A, Teede H, Louwers YV.
Fertil Steril. 2024 Oct;122(4):727-739. doi: 10.1016/j.fertnstert.2024.05.163. Epub 2024 Jun 27.